Cargando…
Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma
Objective: Resistance to immune checkpoint inhibitors (ICIs) has been a massive obstacle to ICI treatment in metastatic urothelial carcinoma (MUC). Recently, increasing evidence indicates the clinical importance of the association between hypoxia and immune status in tumor patients. Therefore, it is...
Autores principales: | Hong, Shuo, Zhang, Yueming, Cao, Manming, Lin, Anqi, Yang, Qi, Zhang, Jian, Luo, Peng, Guo, Linlang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657403/ https://www.ncbi.nlm.nih.gov/pubmed/34901008 http://dx.doi.org/10.3389/fcell.2021.762478 |
Ejemplares similares
-
Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma
por: Zhang, Yueming, et al.
Publicado: (2021) -
Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020) -
MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer
por: Yi, Ruibin, et al.
Publicado: (2022) -
Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer
por: Yang, Li, et al.
Publicado: (2021) -
Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
por: Guan, Bao, et al.
Publicado: (2021)